207 related articles for article (PubMed ID: 23065484)
1. Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family.
Abd El Kader T; Kubota S; Janune D; Nishida T; Hattori T; Aoyama E; Perbal B; Kuboki T; Takigawa M
J Cell Commun Signal; 2013 Mar; 7(1):11-8. PubMed ID: 23065484
[TBL] [Abstract][Full Text] [Related]
2. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
[TBL] [Abstract][Full Text] [Related]
3. Metabolic regulation of the CCN family genes by glycolysis in chondrocytes.
Akashi S; Nishida T; El-Seoudi A; Takigawa M; Iida S; Kubota S
J Cell Commun Signal; 2018 Mar; 12(1):245-252. PubMed ID: 29129024
[TBL] [Abstract][Full Text] [Related]
4. Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage.
Kawaki H; Kubota S; Suzuki A; Lazar N; Yamada T; Matsumura T; Ohgawara T; Maeda T; Perbal B; Lyons KM; Takigawa M
J Bone Miner Res; 2008 Nov; 23(11):1751-64. PubMed ID: 18597638
[TBL] [Abstract][Full Text] [Related]
5. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
6. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
7. CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.
Riser BL; Najmabadi F; Perbal B; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC; Peterson DR
J Cell Commun Signal; 2010 Mar; 4(1):39-50. PubMed ID: 20195391
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Genetic Interactions between CCN2 and CCN3 behind Their Yin-Yang Collaboration.
Kubota S; Kawata K; Hattori T; Nishida T
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682564
[TBL] [Abstract][Full Text] [Related]
9. Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2.
Leask A
J Cell Commun Signal; 2009 Jun; 3(2):161-2. PubMed ID: 19475498
[TBL] [Abstract][Full Text] [Related]
10. Effects of CCN3 on fibroblast proliferation, apoptosis and extracellular matrix production.
Ren Z; Hou Y; Ma S; Tao Y; Li J; Cao H; Ji L
Int J Mol Med; 2014 Jun; 33(6):1607-12. PubMed ID: 24715059
[TBL] [Abstract][Full Text] [Related]
11. Spatial-temporal modulation of CCN proteins during wound healing in human skin in vivo.
Rittié L; Perbal B; Castellot JJ; Orringer JS; Voorhees JJ; Fisher GJ
J Cell Commun Signal; 2011 Mar; 5(1):69-80. PubMed ID: 21484592
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
[TBL] [Abstract][Full Text] [Related]
13. CCN3, a key matricellular protein, distinctly inhibits TGFβ1-mediated Smad1/5/8 signalling in human podocyte culture.
Madne TH; Dockrell MEC
Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):5-10. PubMed ID: 29506624
[TBL] [Abstract][Full Text] [Related]
14. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.
Lin CG; Leu SJ; Chen N; Tebeau CM; Lin SX; Yeung CY; Lau LF
J Biol Chem; 2003 Jun; 278(26):24200-8. PubMed ID: 12695522
[TBL] [Abstract][Full Text] [Related]
15. Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.
Wu Q; Jorgensen M; Song J; Zhou J; Liu C; Pi L
Gastroenterol Res Pract; 2016; 2016():2313850. PubMed ID: 27829832
[TBL] [Abstract][Full Text] [Related]
16. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
17. Expression of CCN family of genes in human skin in vivo and alterations by solar-simulated ultraviolet irradiation.
Quan T; Shin S; Qin Z; Fisher GJ
J Cell Commun Signal; 2009 Mar; 3(1):19-23. PubMed ID: 19319669
[TBL] [Abstract][Full Text] [Related]
18. RFX1-mediated CCN3 induction that may support chondrocyte survival under starved conditions.
Mizukawa T; Nishida T; Akashi S; Kawata K; Kikuchi S; Kawaki H; Takigawa M; Kamioka H; Kubota S
J Cell Physiol; 2021 Oct; 236(10):6884-6896. PubMed ID: 33655492
[TBL] [Abstract][Full Text] [Related]
19. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
20. The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.
Zuo GW; Kohls CD; He BC; Chen L; Zhang W; Shi Q; Zhang BQ; Kang Q; Luo J; Luo X; Wagner ER; Kim SH; Restegar F; Haydon RC; Deng ZL; Luu HH; He TC; Luo Q
Histol Histopathol; 2010 Jun; 25(6):795-806. PubMed ID: 20376786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
